Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial.

Eur Respir J · 2013 · PMC3787815 · PMID 23349444

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Indeed, our randomised clinical trial showed a nonsignificant trend for reduction of LOS during the initial encounter (point estimate 0.5 days) and for overall hospitalisations (point estimate 0.7 days) within 90 days in the proADM-enhanced compared with the control group.

also in 5,406 other papers

did not reach statistical significanceno p-value reported

Interestingly, this equals our point estimate of shortening of LOS, even though it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.